Data & APIsEventsMarketfyPremarketBoost
Contribute Login Join
Data & APIs
Events
Marketfy
Premarket
Boost

Plc Astrazeneca Net Worth & Insider Trades

Plc Astrazeneca Aevi Genomic Medicine, Inc

As of February 7, 2020

What is Plc Astrazeneca's Net Worth?

The current estimated net worth of Aevi Genomic Medicine, Inc's Plc Astrazeneca is estimated to be about $358.09M . Plc Astrazeneca owns about 12,946,900 units of Aevi Genomic Medicine, Inc common stock. Recently at Aevi Genomic Medicine, Inc, Plc Astrazeneca has sold an estimated value of $0 worth.

What is Plc Astrazeneca's Past Insider Trading?

In total, Plc Astrazeneca has made about 1 transaction recently at Aevi Genomic Medicine, Inc. Plc Astrazeneca usually trades in February, with the busiest year in 2020. The most recent transaction was a purchase order of 12,946,900 units , worth over $0 on February 7, 2020.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

PLC ASTRAZENECA, MedImmune Ltd

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is Plc Astrazeneca's' Mailing Address?

  • Mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge X0 CB2 0AA United Kingdom

What are Aevi Genomic Medicine, Inc's Past Insider Trades?

Aevi Genomic Medicine, Inc's most recent insider trade came on February 7, 2020 by Plc Astrazeneca and Medimmune Ltd who bought 12,946,900 units worth $0 . In the last 2 years, insiders at Aevi Genomic Medicine, Inc have sold an estimated value of $599.23K and bought an estimated value of $8.71M worth of shares. Insider trading is most common in February, with the busiest year in 2017. The most active traders at the company are Sol J Barer, Director,  Garry A. Neil, Chief Scientific Officer,  and Michael F Cola, President and CEO .

Aevi Genomic Medicine, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...